| Association of blood pressure classification in young adults using the 2017 American College of Cardiology/American Heart Association blood pressure guideline with … Y Yano, JP Reis, LA Colangelo, D Shimbo, AJ Viera, NB Allen, ... Jama 320 (17), 1774-1782, 2018 | 316 | 2018 |
| Cost-effectiveness of intensive versus standard blood-pressure control AP Bress, BK Bellows, JB King, R Hess, S Beddhu, Z Zhang, DR Berlowitz, ... New England Journal of Medicine 377 (8), 745-755, 2017 | 202 | 2017 |
| Left atrial fibrosis and risk of cerebrovascular and cardiovascular events in patients with atrial fibrillation JB King, PN Azadani, P Suksaranjit, AP Bress, DM Witt, FT Han, ... Journal of the American College of Cardiology 70 (11), 1311-1321, 2017 | 182 | 2017 |
| Generalizability of SPRINT results to the US adult population AP Bress, RM Tanner, R Hess, LD Colantonio, D Shimbo, P Muntner Journal of the American College of Cardiology 67 (5), 463-472, 2016 | 177 | 2016 |
| Cost-effectiveness of sacubitril-valsartan combination therapy compared with enalapril for the treatment of heart failure with reduced ejection fraction JB King, RU Shah, AP Bress, RE Nelson, BK Bellows JACC: Heart Failure 4 (5), 392-402, 2016 | 144 | 2016 |
| The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy D Brixner, E Biltaji, A Bress, S Unni, X Ye, T Mamiya, K Ashcraft, ... Journal of medical economics 19 (3), 213-228, 2016 | 144 | 2016 |
| Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) intensive blood pressure regimen in the … AP Bress, H Kramer, R Khatib, S Beddhu, AK Cheung, R Hess, VK Bansal, ... Circulation 135 (17), 1617-1628, 2017 | 114 | 2017 |
| Trends in antihypertensive medication discontinuation and low adherence among Medicare beneficiaries initiating treatment from 2007 to 2012 GS Tajeu, ST Kent, IM Kronish, L Huang, M Krousel-Wood, AP Bress, ... Hypertension 68 (3), 565-575, 2016 | 103 | 2016 |
| Trends in antihypertensive medication monotherapy and combination use among US adults, National Health and Nutrition Examination Survey 2005–2016 CG Derington, JB King, JS Herrick, D Shimbo, IM Kronish, JJ Saseen, ... Hypertension 75 (4), 973-981, 2020 | 99 | 2020 |
| Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans K Drozda, S Wong, SR Patel, AP Bress, EA Nutescu, RA Kittles, ... Pharmacogenetics and genomics 25 (2), 73-81, 2015 | 95 | 2015 |
| Effects of intensive systolic blood pressure lowering on cardiovascular events and mortality in patients with type 2 diabetes mellitus on standard glycemic control and in those … S Beddhu, GM Chertow, T Greene, PK Whelton, WT Ambrosius, ... Journal of the American Heart Association 7 (18), e009326, 2018 | 92 | 2018 |
| Neprilysin inhibition in heart failure with reduced ejection fraction: a clinical review JB King, AP Bress, AD Reese, MA Munger Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (9 …, 2015 | 88 | 2015 |
| Effect of intensive versus standard blood pressure treatment according to baseline prediabetes status: a post hoc analysis of a randomized trial AP Bress, JB King, KE Kreider, S Beddhu, DL Simmons, AK Cheung, ... Diabetes Care 40 (10), 1401-1408, 2017 | 81 | 2017 |
| Feasibility of implementing a comprehensive warfarin pharmacogenetics service EA Nutescu, K Drozda, AP Bress, WL Galanter, J Stevenson, TD Stamos, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (11 …, 2013 | 80 | 2013 |
| Revisiting warfarin dosing using machine learning techniques A Sharabiani, A Bress, E Douzali, H Darabi Computational and mathematical methods in medicine 2015 (1), 560108, 2015 | 78 | 2015 |
| Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic–Americans and African–Americans A Bress, SR Patel, MA Perera, RT Campbell, RA Kittles, LH Cavallari Pharmacogenomics 13 (16), 1925-1935, 2012 | 74 | 2012 |
| Intensive vs standard blood pressure control in adults 80 years or older: a secondary analysis of the systolic blood pressure intervention trial NM Pajewski, DR Berlowitz, AP Bress, KE Callahan, AK Cheung, LJ Fine, ... Journal of the American Geriatrics Society 68 (3), 496-504, 2020 | 72 | 2020 |
| Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial SR Rapp, SA Gaussoin, BC Sachs, G Chelune, MA Supiano, AJ Lerner, ... The Lancet Neurology 19 (11), 899-907, 2020 | 69 | 2020 |
| 2017 ACC/AHA blood pressure treatment guideline recommendations and cardiovascular risk LD Colantonio, JN Booth, AP Bress, PK Whelton, D Shimbo, EB Levitan, ... Journal of the American College of Cardiology 72 (11), 1187-1197, 2018 | 63 | 2018 |
| Role of cytochrome P450 genotype in the steps toward personalized drug therapy LH Cavallari, H Jeong, A Bress Pharmacogenomics and personalized medicine, 123-136, 2011 | 58 | 2011 |
Jordan KingUniversity of Utah在 hsc.utah.edu 的电子邮件经过验证
